Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons

Genomics

Volumn 67, Issue 2, 2000, Pages 146-152

  Horie, Masato ^a   Mitsumoto, Yasuhide ^a   Kyushiki, Hiroyuki ^a   Kanemoto, Naohide ^a   Watanabe, Akihito ^a   Taniguchi, Yoshihiro ^a   Nishino, Naoki ^a   Okamoto, Takashi ^a   Kondo, Mari ^a   Mori, Toyoki ^a   Noguchi, Koichi ^b   Nakamura, Yusuke ^c   Takahashi, Ei Ichi ^a   Tanigami, Akira ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; DENTATE GYRUS; FETUS; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA; MAMMALIA;

EID: 18144435003     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6228     Document Type: Article

References (23)

1. Abe K., Takayanagi M., Saito H. Effects of recombinant human basic fibroblast growth factor and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain. Jpn. J. Pharmacol. 53:1990;221-227.
2. Carpenter G., Wahl M. I. Epidermal growth factor family. Spoorn M. B., Roberts A. B. Handbook of Experimental Pharmacology. 1990;67-171 Springer-Verlag, Berlin.
3. Davis C. G. The many faces of epidermal growth factor repeats. New Biol. 2:1990;410-419.
4. Eib D. W., Martens G. J. A novel transmembrane protein with epidermal growth factor and follistatin domains expressed in the hypothalamo-hypophysial axis of Xenopus laevis. J. Neurochem. 67:1996;1047-1055.
5. Engler D. A., Montelione G. T., Niyogi S. K. Human epidermal growth factor: Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy. FEBS Lett. 271:1990;47-50.
6. Ferns M. J., Hall Z. W. How many agrins does it take to make a synapse? Cell. 70:1992;1-3.
7. Higgins D. G., Bleasby A. J., Fuchs R. CLUSTAL V: Improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:1992;189-191.
8. Hirota S., Ito A., Morii E., Wanaka A., Tohyama M., Kitamura Y., Nomura S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: An analysis using the in situ hybridization. Mol. Brain Res. 15:1992;47-54.
9. Hou J. G., Lin L.-F. H., Mytilineou C. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66:1996;74-82.
10. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
11. Knusel B., Michel P. P., Schwaber J. S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and insulin-like growth factors I and II. J. Neurosci. 10:1990;558-570.
12. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M. J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P. J., Wilkinson K. D., Polymeropoulos M. H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
13. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for mid brain dopaminergic neurons. Science. 260:1993;1130-1132.
14. Lin L.-F. H., Zhang T. J., Collins F., Armes L. G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
15. Marchionni M. A., Goodearl A. D., Chen M. S., Bermingham-McDonogh O., Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J., Kobayashi K., Wroblewski D., Lynch C., Baldassare M., Hiles I., Davis J. B., Hsuan J., Totty J. J., Otsu M., McBurney R. N., Waterfield M. D., Stroobant P., Gwynne D. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature. 362:1993;312-318.
16. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
17. Rupp F., Payan D. G., Magill-Solc C., Cowan D. M., Scheller R. H. Structure and expression of a rat agrin. Neuron. 6:1991;811-823.
18. Sannes L. J. Executive summary. Cuddihee C., Donovan S., Graffam S., Kaiser C. L. The Outlook for Neurodegenerative Disease Therapy Markets. 1996;1-9 Decision Resources Publication, Waltham.
19. Shimoda K., Sauve Y., Marini A., Schwartz J. P., Comissiong J. W. A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586:1992;319-331.
20. Small D. H., Mok S. S., Williamson T. G., Nurcombe V. Role of proteoglycans in neural development, regeneration, and the aging brain. J. Neurochem. 67:1996;889-899.
21. Tsen G., Halfter W., Kroger S., Cole G. J. Agrin is a heparan sulfate proteoglycan. J. Biol. Chem. 270:1995;3392-3399.
22. Tsim K. W., Ruegg M. A., Escher G., Kroger S., McMahan U. J. cDNA that encodes active agrin. Neuron. 8:1992;677-689.
23. Yamada H., Watanabe K., Shimonaka M., Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. 269:1994;10119-10126.